The effect of treatment with recombinant human follicle stimulating hormone (rhFSH), human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) on semen parameters after varicocelectomy: a randomized clinical trial.
Not Applicable
- Conditions
- infertility.Male infertility
- Registration Number
- IRCT201112248509N1
- Lead Sponsor
- rology and Nephrology Research Center of Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 120
Inclusion Criteria
infertility after 12 months of unprotected intercourse; male factor infertility due to varicocele; spontaneous onset of maturation and normal sexual development
Exclusion criteria: presence of infertility due to any other factor especially female infertility; systemic disease; underlying testis abnormalities; abnormal reproductive hormone levels.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sperm parameters. Timepoint: before initiation of treatment and further control examinations were performed 8 to 10 weeks after the completion of each period of treatment. Method of measurement: spermogram.
- Secondary Outcome Measures
Name Time Method Pregnancy. Timepoint: 6 month. Method of measurement: bHCG.